757.40美元8.04(1.07%)
2024/12/20更新
績效 / 1月3.84%
3月11.17%
1年5.72%
晨星評等 - 1.現金0.41%
- 2.股票8.56%
- 3.債券0.02%
- 4.其他91.01%
- 1.美國91.02%
- 2.歐洲不包含歐元區4.20%
- 3.歐元區2.78%
- 4.加拿大1.58%
- 1.argenx SE ADR5.67%
- 2.Insmed Inc4.52%
- 3.Sarepta Therapeutics Inc4.05%
- 4.Intra-Cellular Therapies Inc4.01%
- 5.TG Therapeutics Inc3.30%
- 6.Vaxcyte Inc Ordinary Shares3.24%
- 7.Blueprint Medicines Corp3.10%
- 8.Gilead Sciences Inc3.01%
- 9.SpringWorks Therapeutics Inc Ordinary Shares2.81%
- 10.Cytokinetics Inc2.80%
- 1.現金0.41%
- 2.股票8.56%
- 3.債券0.02%
- 4.其他91.01%
- 1.美國91.02%
- 2.歐洲不包含歐元區4.20%
- 3.歐元區2.78%
- 4.加拿大1.58%
- 1.argenx SE ADR5.67%
- 2.Insmed Inc4.52%
- 3.Sarepta Therapeutics Inc4.05%
- 4.Intra-Cellular Therapies Inc4.01%
- 5.TG Therapeutics Inc3.30%
- 6.Vaxcyte Inc Ordinary Shares3.24%
- 7.Blueprint Medicines Corp3.10%
- 8.Gilead Sciences Inc3.01%
- 9.SpringWorks Therapeutics Inc Ordinary Shares2.81%
- 10.Cytokinetics Inc2.80%